BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2025 9:21:16 AM | Browse: 149 | Download: 225
 |
Received |
|
2025-04-25 10:57 |
 |
Peer-Review Started |
|
2025-04-25 10:57 |
 |
First Decision by Editorial Office Director |
|
2025-05-08 19:26 |
 |
Return for Revision |
|
2025-05-10 16:50 |
 |
Revised |
|
2025-05-22 00:56 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-07-25 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-07-25 08:56 |
 |
Articles in Press |
|
2025-07-25 08:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-08-14 07:21 |
 |
Publish the Manuscript Online |
|
2025-08-27 09:21 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Duodenal mucosal ablation by irreversible electroporation: Modulating the gut-liver axis in metabolic steatotic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariana M Ramírez-Mejía and Nahum Méndez-Sánchez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nahum Méndez-Sánchez, AGAF, FAASLD, FACG, MD, PhD, Liver Research Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, Col. Toriello Guerra, Mexico City 14050, Mexico. nah@unam.mx |
| Key Words |
Gut‒Liver Axis; Metabolic dysfunction-associated steatotic liver disease; Duodenal mucosa ablation; Intestinal permeability; Lipids |
| Core Tip |
Duodenal mucosal ablation (DMA) via irreversible electroporation has emerged as a novel strategy to modulate the gut–liver axis in metabolic dysfunction-associated steatotic liver disease (MASLD). In this letter, we analyzed recent preclinical evidence from Yu et al, who reported that DMA leads to reduced hepatic steatosis, improved lipid profiles, and enhanced intestinal barrier integrity. We contextualize these findings within the physiology of the duodenum and explore their translational potential as a minimally invasive therapeutic approach in MASLD. |
| Publish Date |
2025-08-27 09:21 |
| Citation |
Ramírez-Mejía MM, Méndez-Sánchez N. Duodenal mucosal ablation by irreversible electroporation: Modulating the gut-liver axis in metabolic steatotic liver disease. World J Hepatol 2025; 17(8): 108845 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i8/108845.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i8.108845 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345